Back

SGLT2 inhibitors for the treatment of heart failure.

31 August 2020 (11:05 - 11:15)
Organised by:
Congress Presentation Part of: Pharmacological Treatment of Chronic Heart Failure Treatment ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Old drugs in the modern era: ACEI/ARB, MRAs+digoxin.
Professor M. Pfeffer (Boston, US)
Slides Video
Presentation thumbnail
New drugs on the horizon: sGC stimulators, myosin activators.
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Sacubitril/valsartan: opportunities and challenges.
Professor J. McMurray (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Pharmacological Treatment of Chronic Heart Failure

The Event

Event poster

ESC Congress 2020

31 August 2020 11:05 CET
You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of SGLT2 inhibitors in diabetic and non-diabetic heart failure patients, a meta-analysis of randomized controlled trials
29 August 2022
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources